Comprehensive Investigation: Our study comprehensively examined the role of the senescence-related gene RRM2, the ANXA1 protein, and the PI3K/AKT pathway in regulating sensitivity to docetaxel therapy in prostate cancer. This evidence concerns the gene ANXA1 and Familial prostate cancer.